Correlation of biomarkers and bone mineral density for osteoporosis in post-menopausal women

Authors

  • K. Hymavathi Department of Obstetrics and Gynaecology, Narayana Medical College and Hospital, Nellore, Andhra Pradesh, India
  • Tejaswini Jakka Department of Obstetrics and Gynaecology, Narayana Medical College and Hospital, Nellore, Andhra Pradesh, India
  • Bhaavya Paturi Department of Obstetrics and Gynaecology, Narayana Medical College and Hospital, Nellore, Andhra Pradesh, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20200366

Keywords:

Bone mineral density, Dual-energy X-ray, Postmenopausal osteoporosis, Urinary excretion of hydroxyproline

Abstract

Background: Osteoporosis is a metabolic bone disorder characterised by a low bone mass and microarchitectural deterioration of bone tissue followed by enhanced bone fragility and a consequent rise in fracture risk. Aim of the study is to correlate the biomarkers and bone mineral density in postmenopausal osteoporosis.

Methods: This is a prospective study done in the department of obstetrics and gynaecology, Narayana medical College and Hospital, Nellore for a period of 2 years (October 2016-October 2018). This study was designed to assess the correlation between bone mineral density (BMD) and various biochemical markers.

Results: The mean age of the present study is 60.51±9.35 years. There is a significant correlation found between age, serum phosphorus, urinary OHPr and bone mineral density. The mean BMI of the present study is 24.75±4.25 kg/m2. There is a significant correlation observed between BMI, serum ionized calcium, urinary OHPr and bone mineral density. There exists a significant correlation between BMD and urinary OHPr. It is found that in menopausal women spine and hip are the major sites affected by osteoporosis. The early changes are found in lumbar spine compared to hip. In the present study with increase in BMI there is increase in BMD signifying obesity is a protective factor for osteoporosis leaving aside all it’s ill effects. Urinary hydroxyproline a marker of resorption is found to have a negative correlation with BMD.

Conclusions: BMD measurements using DEXA are not readily available in India. Biochemical markers of bone remodelling are useful tools in assessment of osteoporosis and are safe, inexpensive, easily performed. In the present study an attempt is made to correlate biochemical markers and BMD so as to detect osteoporosis even before the changes being evident on imaging studies.

References

Watts NB. Postmenopausal osteoporosis: a clinical review. J Women’s Health. 2018.

Pardhe BD, Pathak S, Bhetwal A, Ghimire S, Shakya S, Khanal PR, et al. Effect of age and estrogen on biochemical markers of bone turnover in postmenopausal women: a population-based study from Nepal. Int J Women’s Health. 2017;9:781-8.

Indumati V, Patil VS, Jailkhani R. Hospital based preliminary study on osteoporosis in postmenopausal women. Indian J Clin Biochem. 2007;22(2):96-100.

Bhattachaeyya S, Siegel ER, Achenbach SJ, Khosla S, Suva LJ. Serum biochemical profile associated with high bone turnover and BMD in postmenopausal women. J Bone Mineral Res. 2008;23.

Sharma S, Agarwal B, Sharma R, Singh S. Forearm bone mineral density in postmenopausal Indian women: correlation with calcium nutrition. 2017;6(10):4339-46.

Rekha P, Venkateswarulu U, Sarada U. Comparative study of biochemical bone turn over markers in pre and postmenopausal women. Int J Applied Res. 2015;1(5):185-7.

Sajjanar DS, Sajjanar SL. Study of serum alkaline phosphatase, calcium and urinary hydroxyproline as bone biomarkers in postmenopausal women. Int J Basic Appl Med Sci. 2014;4(1):223-9.

Gandhi A, Shukla AK. Evaluation of BMD of women above 40 years of age. J Obstet Gynecol India. 2005;55(3):265-7.

Isaia G, Mussetta M, Di Stefano M, Sciolla A, Triolo S, Molinatti GM. Metabolic markers for the early diagnosis of postmenopausal osteoporosis. J Endocrinol Invest. 1994;17(10):771-4.

de Carvalho Pereira D, Lima RP, de Lima RT, Gonçalves MD, de Morais LC, Franceschini SD, et al. Association between obesity and calcium: phosphorus ratio in the habitual diets of adults in a city of Northeastern Brazil: an epidemiological study. Nutrit J. 2013;12(1):90.

Khan AR, Awan FR, Najam S, Islam M, Siddique T, Zain M. Elevated serum level of human alkaline phosphatase in obesity. Age (years). 2015;48(8.8):42-5.

Sharma S, Agarwal B, Sharma R, Singh S. Forearm bone mineral density in postmenopausal Indian women: correlation with calcium nutrition. Int J Reprod Contracept Obstet Gynecol. 2017;6:4339-46.

Keen RW, Nguyen T, Sobnack R, Perry LA, Thompson PW, Spector TD. Can biochemical markers predict bone loss at the hip and spine?: a 4-year prospective study of 141 early postmenopausal women. Osteoporosis Int. 1996;6(5):399-406.

D'Erasmo E, Pisani D, Ragno A, Raejntroph N, Letizia C, Acc M. Relationship between serum albumin and bone mineral density in postmenopausal women and in patients with hypoalbuminemia. Horm Metab Res. 1999;31:385-8.

Kuo TR, Chen CH. Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives. Biomarker Res. 2017;5(1):18.

Civitelli R, Gonnelli S, Zacchei F, Bigazzi S, Louis AV, Gennarit C. Bone turnover in postmenopausal osteoporosis. J Clin Invest. 1988;82(4):1268-74.

Downloads

Published

2020-01-28

Issue

Section

Original Research Articles